Drug & intervention
fosnetupitant 235 MG / palonosetron 0.25 MG [Akynzeo]
RxCUI 2044430
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
AkynzeoBN · CureCurrent ID 58560
netupitant / palonosetron Injection [Akynzeo]SBDF · CureCurrent ID 67000
netupitant / palonosetron Oral Capsule [Akynzeo]SBDF · CureCurrent ID 58562
netupitant 300 MG / palonosetron 0.5 MG [Akynzeo]SBDC · CureCurrent ID 58561
netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]SBD · CureCurrent ID 58563
fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML [Akynzeo]SBDC · CureCurrent ID 70973
fosnetupitant 235 MG / palonosetron 0.25 MG Injection [Akynzeo]SBD · CureCurrent ID 67005
20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection [Akynzeo]SBD · CureCurrent ID 70974
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.